{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:38:43Z","timestamp":1787319523800,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771661"],"award-info":[{"award-number":["81771661"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373188"],"award-info":[{"award-number":["81373188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671618"],"award-info":[{"award-number":["81671618"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine","award":["2017-I2M-3-001"],"award-info":[{"award-number":["2017-I2M-3-001"]}]},{"name":"CAMS Initiative for Innovative Medicine","award":["2017-I2M-B&R-01"],"award-info":[{"award-number":["2017-I2M-B&R-01"]}]},{"name":"National Key Research and Development Program of China","award":["2016YFC0903900"],"award-info":[{"award-number":["2016YFC0903900"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.clim.2019.01.001","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T14:47:15Z","timestamp":1546526835000},"page":"10-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["High levels of antibodies to citrullinated \u03b1-enolase peptide-1 (CEP-1) identify erosions and interstitial lung disease (ILD) in a Chinese rheumatoid arthritis cohort"],"prefix":"10.1016","volume":"200","author":[{"given":"Yudong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liubing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengchun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2019.01.001_bb0005","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/BOR.0000000000000380","article-title":"Recent advances in the pathogenesis, prediction, and management of rheumatoid arthritis-associated interstitial lung disease","volume":"29","author":"Johnson","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.clim.2019.01.001_bb0010","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/BOR.0b013e32835fd7f8","article-title":"Rheumatoid arthritis and cardiovascular disease: an update on treatment issues","volume":"25","author":"Barbhaiya","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"issue":"2017","key":"10.1016\/j.clim.2019.01.001_bb0015","first-page":"7915340","article-title":"Clinical, epidemiological, and histopathological features of respiratory involvement in rheumatoid arthritis","author":"Alunno","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.clim.2019.01.001_bb0020","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3389\/fimmu.2018.01113","article-title":"Comparison of serological biomarkers in rheumatoid arthritis and their combination to improve diagnostic performance","volume":"9","author":"Martinez-Prat","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2019.01.001_bb0025","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93688","article-title":"Anti-citrullinated protein antibodies cause arthritis by cross-reactivity to joint cartilage","volume":"2","author":"Ge","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.clim.2019.01.001_bb0030","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.autrev.2009.11.017","article-title":"Profiling of rheumatoid arthritis associated autoantibodies","volume":"9","author":"Conrad","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2019.01.001_bb0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/BOR.0000000000000277","article-title":"The role of anticitrullinated protein antibodies in the early stages of rheumatoid arthritis","volume":"28","author":"Dekkers","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.clim.2019.01.001_bb0040","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/ard.2004.033571","article-title":"Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression","volume":"64","author":"Ronnelid","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2019.01.001_bb0045","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/ard.2003.016808","article-title":"Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project)","volume":"63","author":"Kastbom","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2019.01.001_bb0050","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90045","article-title":"A molecular signature of preclinical rheumatoid arthritis triggered by dysregulated PTPN22","volume":"1","author":"Chang","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.clim.2019.01.001_bb0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.01.001_bb0060","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/ard.2007.075192","article-title":"Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells","volume":"67","author":"Makrygiannakis","year":"2008","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2019.01.001_bb0065","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1146\/annurev.immunol.26.021607.090244","article-title":"Immunity to citrullinated proteins in rheumatoid arthritis","volume":"26","author":"Klareskog","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2019.01.001_bb0070","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.01.001_bb0075","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/art.23284","article-title":"Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen","volume":"58","author":"Clavel","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.01.001_bb0080","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.biocel.2008.09.012","article-title":"Evolutionarily conserved antigens in autoimmune disease: implications for an infective aetiology","volume":"41","author":"Wegner","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.clim.2019.01.001_bb0085","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1002\/art.23936","article-title":"Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase","volume":"58","author":"Lundberg","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.01.001_bb0090","doi-asserted-by":"crossref","first-page":"R1421","DOI":"10.1186\/ar1845","article-title":"Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis","volume":"7","author":"Kinloch","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2019.01.001_bb0095","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/ard.2008.091355","article-title":"Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles","volume":"68","author":"Snir","year":"2009","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2019.01.001_bb0100","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.23618","article-title":"Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis","volume":"58","author":"Kinloch","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.01.001_bb0105","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.25036","article-title":"Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients","volume":"62","author":"Snir","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.01.001_bb0110","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ng.480","article-title":"Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis","volume":"41","author":"Mahdi","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2019.01.001_bb0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.0105-2896.2009.00850.x","article-title":"Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis","volume":"233","author":"Wegner","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2019.01.001_bb0120","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/art.39827","article-title":"Differences in the spectrum of anti-citrullinated protein antibody fine specificities between Malaysian and Swedish patients with rheumatoid arthritis: implications for disease pathogenesis","volume":"69","author":"Too","year":"2017","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.01.001_bb0125","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.01.001_bb0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.01.001_bb0135","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.clim.2017.09.012","article-title":"Antibodies against citrullinated alpha enolase peptides in primary Sjogren's syndrome","volume":"183","author":"Nezos","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2019.01.001_bb0140","series-title":"User Verification of Performance for Precision and Trueness; Approved Guideline, CLSI Document EP15-A2","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2005"},{"key":"10.1016\/j.clim.2019.01.001_bb0145","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1002\/art.39283","article-title":"Local Joint inflammation and histone citrullination in a murine model of the transition from preclinical autoimmunity to inflammatory arthritis","volume":"67","author":"Sohn","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2019.01.001_bb0150","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1546-0096-9-8","article-title":"Evidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritis","volume":"9","author":"Gilliam","year":"2011","journal-title":"Pediatr. Rheumatol. Online J."},{"key":"10.1016\/j.clim.2019.01.001_bb0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1546-0096-11-31","article-title":"Evaluation of anti-citrullinated type II collagen and anti-citrullinated vimentin antibodies in patients with juvenile idiopathic arthritis","volume":"11","author":"Gilliam","year":"2013","journal-title":"Pediatr. Rheumatol. Online J."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618306727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618306727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:44:14Z","timestamp":1565225054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661618306727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":31,"alternative-id":["S1521661618306727"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2019.01.001","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High levels of antibodies to citrullinated \u03b1-enolase peptide-1 (CEP-1) identify erosions and interstitial lung disease (ILD) in a Chinese rheumatoid arthritis cohort","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2019.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}